Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

MLA

Harter, Philipp, et al. Prevalence of Deleterious Germline Variants in Risk Genes Including BRCA1/2 in Consecutive Ovarian Cancer Patients (AGO-TR-1). 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280250821&authtype=sso&custid=ns315887.

APA

Harter, P., Hauke, J., Heitz, F., Reuss, A., Kommoss, S., Marme, F., Heimbach, A., Prieske, K., Richters, L., Burges, A., Neidhardt, G., de Gregorio, N., El-Balat, A., Hilpert, F., Meier, W., Kimmig, R., Kast, K., Sehouli, J., Baumann, K., … Schmutzler, R. (2017). Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

Chicago

Harter, Philipp, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marme, Andre Heimbach, et al. 2017. “Prevalence of Deleterious Germline Variants in Risk Genes Including BRCA1/2 in Consecutive Ovarian Cancer Patients (AGO-TR-1).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280250821&authtype=sso&custid=ns315887.